ABCB1 Genotype and CSF β-Amyloid in Alzheimer Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Geriatric Psychiatry and Neurology

• Publication date

  2011-04-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0891988711402325PMID 21478475PMCID PMC3293495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

  2009cited by this paper
• ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research

  2007cited by this paper
• MDR1‐P‐Glycoprotein (ABCB1) Mediates Transport of Alzheimer’s Amyloid‐β Peptides—Implications for the Mechanisms of Aβ Clearance at the Blood–Brain Barrier

  2007cited by this paper
• ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients

  2006cited by this paper
• Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia

  2006cited by this paper
• MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers

  2006cited by this paper
• Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.

  2006cited by this paper
• Psychological stress induces chemoresistance in breast cancer by upregulating mdr1.

  2005cited by this paper
• P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.

  2005cited by this paper
• Drug resistance in brain diseases and the role of drug efflux transporters

  2005cited by this paper
• Characterization of the human MDR1 gene.

  2005cited by this paper
• Characterization of the humanMDR1 gene

  2005cited by this paper
• The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function.

  2004cited by this paper
• Functional Expression and Localization of P-glycoprotein in the Central Nervous System: Relevance to the Pathogenesis and Treatment of Neurological Disorders

  2004cited by this paper
• Importance of P-glycoprotein at blood-tissue barriers.

  2004cited by this paper
• The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease.

  2004cited by this paper
• (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) The Role of MDR1 Genetic Polymorphisms in Interindividual Variability in P-glycoprotein Expression and Function

  2004cited by this paper
• Polymorphisms in Human MDR1 (P‐glycoprotein): Recent Advances and Clinical Relevance

  2004cited by this paper
• Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.

  2002cited by this paper
• Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier.

  2002cited by this paper
• Increased CSF cortisol in AD is a function of APOE genotype

  2001cited by this paper
• beta-Amyloid efflux mediated by p-glycoprotein.

  2001cited by this paper
• β‐Amyloid efflux mediated by p‐glycoprotein

  2001cited by this paper
• The interrelations of migraine, vertigo, and migrainous vertigo

  2001cited by this paper
• Regulation of the multidrug resistance genes by stress signals.

  2000cited by this paper
• Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples.

  1996cited by this paper
• P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

  1996cited by this paper
• Impact of Sample Selection on APOE ∈4 Allele Frequency: A Comparison of Two Alzheimer's Disease Samples

  1996cited by this paper
• Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Host Single Nucleotide Polymorphisms and Biomarkers of Neuronal Damage and Inflammation in People Living with HIV.

  2024cites this paper
• Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta

  2022cites this paper
• Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies

  2021cites this paper
• The exploration of novel Alzheimer's therapeutic agents from the pool of FDA approved medicines using drug repositioning, enzyme inhibition and kinetic mechanism approaches.

  2019cites this paper
• Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood–brain barrier

  2018cites this paper
• Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium.

  2016cites this paper
• Association between ABCB1 polymorphisms and haplotypes and Alzheimer’s disease: a meta-analysis

  2016cites this paper
• 1 ABCB 1 C 3435 T polymorphism influences the risk for Alzheimer ’ s disease

  2016cites this paper
• Opportunities in pharmacogenomics for the treatment of Alzheimer's disease

  2015cites this paper
• Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

  2014cites this paper
• The ABCB1 Transporter in Alzheimer’s Disease

  2014cites this paper
• THE ROLE OF MDR1 IN IMMUNE SYSTEM AND NEURODEGENERATIVE DISORDERS

  2014cites this paper
• ABCB1 C3435T Polymorphism Influences the Risk for Alzheimer’s Disease

  2014cites this paper
• Targeting CNS transporters for treatment of neurodegenerative diseases.

  2014cites this paper
• Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.

  2013cites this paper
• ABC Transporters and the Alzheimer’s Disease Enigma

  2012cites this paper
• Multidrug resistance-associated ABC transporters – too much of one thing, good for nothing

  2012cites this paper
• Variation and evolution of the ABC transporter genes ABCB1, ABCC1, ABCG2, ABCG5 and ABCG8: implication for pharmacogenetics and disease

  2011cites this paper